A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers
Clinical trial NCT03582462 · COMPLETED
Trial details
- NCT number
- NCT03582462
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2019-04-26
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.